Bifidobacterium breve VPro 52 and Probiotic Adherence Variability Based on Host Factors

• Efficacy of Bifidobacterium breve and Lactobacillus casei oral supplementation on necrotizing enterocolitis in very-low-birth-weight preterm infants: a double-blind, randomized, controlled trial.

  • 2011-01
  • RCT · n = 231
  • The American Journal of Clinical Nutrition 93(1)
  • • Taciana Duque Braga
    • G. D. da Silva
    • P. I. D. de Lira
    • Marília de Carvalho Lima

  • PubMed: 20980486
  • DOI: 10.3945/ajcn.2010.29799

  3 Insights on

  • Probiotic Adherence Variability Based on Host Factors

  • High evidence
  • Highly Cited

  Oral supplementation of B. breve and L. casei reduced the occurrence of NEC (Bell's stage ≥ 2).

  Effect

  Beneficial

  Effect size

  Large